Form 4/A for HIMS Hims & Hers Health, Inc.
Accepted 2023-06-08 00:00:00 ET · period of report 2023-06-02 · accession 0001773751-23-000160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-06-08 | 2023-06-02 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale | $9.04 | -2,009 | 383.9K | -0.5% | -$18.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-02 | S | D | 2,009 | $9.04 | 383,938 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.02 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |